Foyston Gordon & Payne Inc Reduces Stock Position in Sanofi (NASDAQ:SNY)
Foyston Gordon & Payne Inc decreased its position in shares of Sanofi (NASDAQ:SNY – Free Report) by 4.7% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 39,578 shares of the company’s stock after selling 1,949 shares during the quarter. Foyston Gordon & […]